ロード中...
Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers
Introduction. ER, PR, and HER2 are routinely available in breast cancer specimens. The purpose of this study is to contrast breast cancer-specific survival for the eight ER/PR/HER2 subtypes with survival of an immunohistochemical surrogate for the molecular subtype based on the ER/PR/HER2 subtypes a...
保存先:
主要な著者: | , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
Hindawi Publishing Corporation
2014
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4058253/ https://ncbi.nlm.nih.gov/pubmed/24955090 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/469251 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|